
|Articles|October 1, 2006
- Volume 0 0
USE OF ASPIRIN AND IBUPROFEN
Author(s)Anna D. Garrett, PharmD, BCPS, CPP
Advertisement
A recent warning issued by the FDA cautions health care providers regarding a potential interaction between lowdose aspirin and ibuprofen. Ex vivo studies have shown that ibuprofen interferes with the antiplatelet effects of aspirin (81 mg immediate-release). This interaction appears to be most significant when ibuprofen is taken within 30 minutes after taking aspirin. The FDA states in the warning:
- Occasional use of ibuprofen is likely to cause minimal risk
- Spacing of ibuprofen at least 30 minutes after, or more than 8 hours before, aspirin ingestion is suggested
- This problem exists only with immediate-release aspirin.
Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.
Articles in this issue
over 19 years ago
Equation for Success: Diabetes Medication, Diet, and Exerciseover 19 years ago
Rx Product Newsover 19 years ago
OTC Product Newsover 19 years ago
can you READ these Rxs?over 19 years ago
Juvenile Anabolic Steroid Abuseover 19 years ago
Compounding Hotlineover 19 years ago
RESPy AWARD: A Role Model for Pharmacy Studentsover 19 years ago
Ouch! Time for Flu Shotsover 19 years ago
Supreme Court Declines to Review Generic Marketing PactsAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
3
ADA 2026: Optimized Inhaled Insulin Dosing Outperforms Subcutaneous Analogs for Postprandial Glucose in T1D
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5






































































































































